Literature DB >> 24421834

Peripheral blood leukocytes and serum nested polymerase chain reaction are complementary methods for monitoring active cytomegalovirus infection in transplant patients.

Pd Andrade1, Mt Fioravanti1, Ebv Anjos1, C De Oliveira1, Dm Albuquerque1, Scb Costa1.   

Abstract

BACKGROUND: Human cytomegalovirus is an important cause of morbidity and mortality in immunocompromised patients. Qualitative polymerase chain reaction (PCR) has proven to be a sensitive and effective technique in defining active cytomegalovirus infection, in addition to having low cost and being a useful test for situations in which there is no need for quantification. Real-time PCR has the advantage of quantification; however, the high cost of this methodology makes it impractical for routine use.
OBJECTIVE: To apply a nested PCR assay to serum (sPCR) and to evaluate its efficiency to diagnose active cytomegalovirus infection compared with PCR of peripheral blood leukocytes (L-PCR).
METHODS: Samples of 37 patients were prospectively evaluated. An internal control was created and applied to sPCR to exclude false-negative results.
RESULTS: In total, 21 patients (57%) developed active cytomegalovirus infection. After analyzing the two methods for the diagnosis of active infection, higher sensitivity and negative predictive value of the L-PCR versus sPCR (100% versus 62%), and higher specificity and positive predictive value of sPCR versus L-PCR (81% versus 50% and 72%, respectively) were observed. Discordant results were observed in 11 patients who were L-PCR-positive but sPCR-negative for active cytomegalovirus infection, five of whom developed clinical symptoms of cytomegalovirus. Clinical symptoms were observed in 14 patients, 12 of whom were diagnosed with active infection by nested L-PCR (P=0.007) and seven by nested sPCR (P=0.02). Higher specificity and a positive predictive value for sPCR were observed.
CONCLUSION: Nested L-PCR and sPCR were considered to be complementary methods for the diagnosis and management of symptomatic cytomegalovirus infection.

Entities:  

Keywords:  CMV; Nested PCR; Serum nested PCR; Transplant

Year:  2013        PMID: 24421834      PMCID: PMC3852461          DOI: 10.1155/2013/214631

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  40 in total

1.  Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.

Authors:  R Loginov; K Höckerstedt; I Lautenschlager
Journal:  Arch Virol       Date:  2003-07       Impact factor: 2.574

Review 2.  Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction.

Authors:  T H The; M van der Ploeg; A P van den Berg; A M Vlieger; M van der Giessen; W J van Son
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

3.  A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.

Authors:  Frank M Mattes; Emma G Hainsworth; Anna-Maria Geretti; Gaia Nebbia; Grant Prentice; Michael Potter; Andrew K Burroughs; Paul Sweny; Aycan F Hassan-Walker; Sylvester Okwuadi; Caroline Sabin; Geraldine Amooty; Vanessa S Brown; Sarah C Grace; Vincent C Emery; Paul D Griffiths
Journal:  J Infect Dis       Date:  2004-04-01       Impact factor: 5.226

4.  Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Authors:  Michael Boeckh; MeeiLi Huang; James Ferrenberg; Terry Stevens-Ayers; Laurence Stensland; W Garrett Nichols; Lawrence Corey
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 5.  Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of human Cytomegalovirus in clinical specimens.

Authors:  H N Madhavan; P Sowmya; K L Therese; J Malathi
Journal:  J Virol Methods       Date:  2007-01-12       Impact factor: 2.014

7.  Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

Authors:  S A Spector; R Wong; K Hsia; M Pilcher; M J Stempien
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

8.  Detection of human cytomegalovirus DNA in immunocompromised children by polymerase chain reaction.

Authors:  H Nishihara; M Ito; N Matsumoto; T Nakano; T Ihara; H Kamiya; M Sakurai
Journal:  Clin Diagn Virol       Date:  1995-01

9.  The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?

Authors:  M M Abecassis; A J Koffron; B Kaplan; M Buckingham; J P Muldoon; A J Cribbins; D B Kaufman; J P Fryer; J Stuart; F P Stuart
Journal:  Transplantation       Date:  1997-01-27       Impact factor: 4.939

10.  Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.

Authors:  L Rasmussen; D Kelsall; R Nelson; W Carney; M Hirsch; D Winston; J Preiksaitis; T C Merigan
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.